Sean Lee
Stock Analyst at HC Wainwright & Co.
(3.95)
# 603
Out of 5,140 analysts
100
Total ratings
31.63%
Success rate
20.22%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRVS Corvus Pharmaceuticals | Maintains: Buy | $11 → $27 | $20.54 | +31.45% | 4 | Jan 20, 2026 | |
| ATEC Alphatec Holdings | Reiterates: Buy | $24 | $16.84 | +42.52% | 14 | Jan 12, 2026 | |
| KZIA Kazia Therapeutics | Maintains: Buy | $13 → $18 | $7.06 | +155.14% | 6 | Dec 12, 2025 | |
| CTSO Cytosorbents | Maintains: Neutral | $1 → $0.75 | $0.69 | +8.79% | 14 | Nov 14, 2025 | |
| SENS Senseonics Holdings | Maintains: Buy | $1.4 → $19 | $7.32 | +152.90% | 3 | Nov 6, 2025 | |
| PSTV Plus Therapeutics | Maintains: Buy | $3 → $2 | $0.29 | +601.02% | 13 | Nov 3, 2025 | |
| NVAX Novavax | Maintains: Buy | $10 → $11 | $9.04 | +21.68% | 2 | Oct 23, 2025 | |
| DWTX Dogwood Therapeutics | Maintains: Buy | $10 → $12 | $2.71 | +342.80% | 2 | Sep 30, 2025 | |
| AKTX Akari Therapeutics, | Reiterates: Buy | $1.6 | $0.26 | +513.03% | 2 | Sep 9, 2025 | |
| CASI CASI Pharmaceuticals | Reiterates: Buy | $4 | $0.96 | +316.67% | 10 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $5 | $0.97 | +416.82% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $6.41 | +118.41% | 14 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $69.40 | -42.36% | 10 | Apr 1, 2025 |
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11 → $27
Current: $20.54
Upside: +31.45%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $16.84
Upside: +42.52%
Kazia Therapeutics
Dec 12, 2025
Maintains: Buy
Price Target: $13 → $18
Current: $7.06
Upside: +155.14%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1 → $0.75
Current: $0.69
Upside: +8.79%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4 → $19
Current: $7.32
Upside: +152.90%
Plus Therapeutics
Nov 3, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.29
Upside: +601.02%
Novavax
Oct 23, 2025
Maintains: Buy
Price Target: $10 → $11
Current: $9.04
Upside: +21.68%
Dogwood Therapeutics
Sep 30, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $2.71
Upside: +342.80%
Akari Therapeutics,
Sep 9, 2025
Reiterates: Buy
Price Target: $1.6
Current: $0.26
Upside: +513.03%
CASI Pharmaceuticals
Sep 3, 2025
Reiterates: Buy
Price Target: $4
Current: $0.96
Upside: +316.67%
Aug 12, 2025
Maintains: Buy
Price Target: $9.5 → $5
Current: $0.97
Upside: +416.82%
May 9, 2025
Maintains: Buy
Price Target: $10 → $14
Current: $6.41
Upside: +118.41%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $69.40
Upside: -42.36%